![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
BlackRock Science and Technology Term Trust | NYSE:BSTZ | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.51 | -2.56% | 19.40 | 19.98 | 19.38 | 19.91 | 213,532 | 19:02:09 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ | ||
Filed by a Party other than the Registrant ☐ | ||
Check the appropriate box: |
||
☐ Preliminary Proxy Statement
☐ Definitive Proxy Statement |
☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
☒ Definitive Additional Materials | ||
☐ Soliciting Material Pursuant to § 240.14a-12 |
BLACKROCK SCIENCE AND TECHNOLOGY TERM TRUST
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. | |
☐ | Fee paid previously with preliminary materials. | |
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Your Vote Matters BlackRock Science and Technology Term Trust (NYSE: BSTZ) BSTZs annual meeting will now take place on July 16 We are very close to receiving enough votes to hold the annual meeting. Your Board consistently takes actions that enhance the value of your investment: 29% Total shareholder returns since 2023, far outpacing peers1 $118m Value generated for shareholders through 9% discount improvement2 10%Additional annual liquidity at NAV through discount management program3 Vote now: FOR the Boards Class II Board Member Nominees AGAINST Sabas proposal to terminate BlackRock as BSTZs investment manager How to vote: Vote online today to make your voice heard BEFORE the meeting on July 16.Vote Now www.proxyvote.com If you have any questions about the proposal to be voted, please feel free to contact Georgeson LLC (Georgeson), toll free at 1-866-529-3057 Important information about the Fund This material is not an advertisement and is intended for existing shareholder use only. This document and the information contained herein relates solely to BlackRock Science and Technology Term Trust (BSTZ). The information contained herein does not relate to, and is not relevant to, any other fund or product sponsored or distributed by BlackRock or any of its affiliates. This document is not an offer to sell any securities and is not a solicitation of an offer to buy any securities. Common shares for the closed-end fund identified above are only available for purchase and sale at current market price on a stock exchange. A closed-end funds dividend yield, market price and NAV will fluctuate with market conditions. The information for this Fund is provided for informational purposes only and does not constitute a solicitation of an offer to buy or sell Fund shares. Performance results reflect past performance and are no guarantee of future results. Current performance may be lower or higher than the performance data quoted. All returns assume reinvestment of all dividends. The market value and net asset value (NAV) of a funds shares will fluctuate with market conditions. Closed-end funds may trade at a premium to NAV but often trade at a discount. © 2024 BlackRock, Inc. or its affiliates. All Rights Reserved. BLACKROCK is a trademark of BlackRock, Inc., or its affiliates. All other trademarks are those of their respective owners. 1 Morningstar as of 5/31/2024; Total shareholder return on price annualized for periods longer than 1 year (assumes dividends are reinvested); Benchmark is the MSCI custom ACWI SMID Growth IT Call Overwrite Index (ex-BSTZ) 2 12/31/2022 5/31/2024; Morningstar/BlackRock data as of 5/31/2024 3 If the funds common shares trade at a discount of more than 7.5% during each of the quarters ended 6/30/24, 9/30/24, 12/31/24 and 3/31/25, the fund intends to offer to repurchase 2.5% of its outstanding common shares at a price equal to 98% of NAV following the end of the applicable quarter. Figure assumes that a tender offer is triggered for each of the quarters listed above.
1 Year BlackRock Science and Te... Chart |
1 Month BlackRock Science and Te... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions